Innoviva announced the creation of Nortiva Bio, a new entity that will build on Langer Lab assets rescued after the collapse of Lyndra Therapeutics. The company aims to develop long‑acting oral medicines and explore drug development alliances.
일일 뉴스2026년 8월 26일•3분 읽기
Innoviva Forms Nortiva Bio to Advance Long‑Acting Oral Medicines
Innoviva has launched Nortiva Bio, using rescued Langer Lab assets to develop long‑acting oral medicines and seek drug development alliances.
Pharmacountry 팀이 정리했습니다 · 출처: FiercePharma
주제:
평점
(0)
(0)
(0)
(0)
(0)
평가 남기기